MLMeng Luan
Meng Luan
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Meng Luan has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Junfu Wang
Shandong Provincial Hospital, Shandong First Medical University, Jinan, China
2 shared publications - Qinghong Su
Shandong Provincial Hospital, Shandong First Medical University, Jinan, China
2 shared publications - Xiaoqun Xu
Shandong Provincial Hospital, Shandong First Medical University, Jinan, China
2 shared publications - Xuemei Chen
Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
2 shared publications - Zhe Song
Yantai Central Blood Station, Yantai, China
2 shared publications - Dali Cheng
Department of Gynaecology and Obstetrics Shengjing Hospital of China Medical University Shenyang Liaoning China
1 shared publication
Latest Publications
- 1 September 2021
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology (Versão em Português)
- Vol. 87 (5) , 521-528
A função da MMP‐2 e MMP‐9 na metástase e no desenvolvimento de carcinoma hipofaríngeo
- 1 September 2021
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology (Versão em Português)
- Vol. 87 (5) , 521-528
A função da MMP‐2 e MMP‐9 na metástase e no desenvolvimento de carcinoma hipofaríngeo
- Open Access
- 1 September 2021
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 87 (5) , 521-528
The role of MMP-2 and MMP-9 in the metastasis and development of hypopharyngeal carcinoma
- 1 September 2021
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 87 (5) , 521-528
Open AccessThe role of MMP-2 and MMP-9 in the metastasis and development of hypopharyngeal carcinoma
- Open Access
- 18 October 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (10) , e0186965
Correction: PD-1 Blockade and OX40 Triggering Synergistically Protects against Tumor Growth in a Murine Model of Ovarian Cancer
[This corrects the article DOI: 10.1371/journal.pone.0089350.].
- 18 October 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (10) , e0186965
Open AccessCorrection: PD-1 Blockade and OX40 Triggering Synergistically Protects against Tumor Growth in a Murine Model of Ovarian Cancer
[This corrects the article DOI: 10.1371/journal.pone.0089350.].